Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Steven

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
Nature Microbiology|September 4, 2024
Diverse RNA viruses of parasitic nematodes can elicit antibody responses in vertebrate hostsShannon Quek, Amber Hadermann, Yang Wu, et al.
Plos Neglected Tropical Diseases|January 17, 2019
Short-course, oral flubendazole does not mediate significant efficacy against Onchocerca adult male worms or Brugia microfilariae in murine infection modelsHanna T Sjoberg, Nicolas Pionnier, Ghaith Aljayyoussi, et al.
Plos Neglected Tropical Diseases|October 27, 2021
X-treme loss of sequence diversity linked to neo-X chromosomes in filarial nematodesJohn Mattick, Silvia Libro, Robin Bromley, et al.
International Journal for Parasitology. Drugs and Drug Resistance|December 24, 2019
Short-course quinazoline drug treatments are effective in the Litomosoides sigmodontis and Brugia pahangi jird modelsMarc P Hübner, Emma Gunderson, Ian Vogel, et al.
BMJ Open Quality|October 2, 2023
Improving fragility hip fracture care through data: a multicentre experience from a country with an emerging economy during the COVID-19 pandemicIrewin A Tabu, Karla Teresa S Araneta, Bernardino B Alpuerto, et al.
Nature Communications|January 4, 2019
Industrial scale high-throughput screening delivers multiple fast acting macrofilaricidesRachel H Clare, Catherine Bardelle, Paul Harper, et al.
Science Translational Medicine|March 15, 2019
Preclinical development of an oral anti-<i>Wolbachia</i> macrolide drug for the treatment of lymphatic filariasis and onchocerciasisMark J Taylor, Thomas W von Geldern, Louise Ford, et al.
Journal of Medicinal Chemistry|February 8, 2019
Boron-Pleuromutilins as Anti- Wolbachia Agents with Potential for Treatment of Onchocerciasis and Lymphatic FilariasisRobert T Jacobs, Christopher S Lunde, Yvonne R Freund, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 9, 2019
AWZ1066S, a highly specific anti-<i>Wolbachia</i> drug candidate for a short-course treatment of filariasisW David Hong, Farid Benayoud, Gemma L Nixon, et al.
Science Translational Medicine|May 10, 2019
Discovery of short-course antiwolbachial quinazolines for elimination of filarial worm infectionsMalina A Bakowski, Roohollah Kazem Shiroodi, Renhe Liu, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Nature Microbiology|September 4, 2024
Diverse RNA viruses of parasitic nematodes can elicit antibody responses in vertebrate hostsShannon Quek, Amber Hadermann, Yang Wu, et al.
Plos Neglected Tropical Diseases|January 17, 2019
Short-course, oral flubendazole does not mediate significant efficacy against Onchocerca adult male worms or Brugia microfilariae in murine infection modelsHanna T Sjoberg, Nicolas Pionnier, Ghaith Aljayyoussi, et al.
Plos Neglected Tropical Diseases|October 27, 2021
X-treme loss of sequence diversity linked to neo-X chromosomes in filarial nematodesJohn Mattick, Silvia Libro, Robin Bromley, et al.
International Journal for Parasitology. Drugs and Drug Resistance|December 24, 2019
Short-course quinazoline drug treatments are effective in the Litomosoides sigmodontis and Brugia pahangi jird modelsMarc P Hübner, Emma Gunderson, Ian Vogel, et al.
BMJ Open Quality|October 2, 2023
Improving fragility hip fracture care through data: a multicentre experience from a country with an emerging economy during the COVID-19 pandemicIrewin A Tabu, Karla Teresa S Araneta, Bernardino B Alpuerto, et al.
Nature Communications|January 4, 2019
Industrial scale high-throughput screening delivers multiple fast acting macrofilaricidesRachel H Clare, Catherine Bardelle, Paul Harper, et al.
Science Translational Medicine|March 15, 2019
Preclinical development of an oral anti-<i>Wolbachia</i> macrolide drug for the treatment of lymphatic filariasis and onchocerciasisMark J Taylor, Thomas W von Geldern, Louise Ford, et al.
Journal of Medicinal Chemistry|February 8, 2019
Boron-Pleuromutilins as Anti- Wolbachia Agents with Potential for Treatment of Onchocerciasis and Lymphatic FilariasisRobert T Jacobs, Christopher S Lunde, Yvonne R Freund, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 9, 2019
AWZ1066S, a highly specific anti-<i>Wolbachia</i> drug candidate for a short-course treatment of filariasisW David Hong, Farid Benayoud, Gemma L Nixon, et al.
Science Translational Medicine|May 10, 2019
Discovery of short-course antiwolbachial quinazolines for elimination of filarial worm infectionsMalina A Bakowski, Roohollah Kazem Shiroodi, Renhe Liu, et al.
Pageof 6